Stacey A Fedewa1, Douglas A Corley2, Christopher D Jensen2, Wei Zhao2, Michael Goodman3, Ahmedin Jemal4, Kevin C Ward3, Theodore R Levin5, Chyke A Doubeni6. 1. Department of Epidemiology, Emory University, Atlanta, Georgia; Surveillance and Health Services Research, American Cancer Society, Atlanta, Georgia. Electronic address: stacey.fedewa@cancer.org. 2. Kaiser Permanente Division of Research, Oakland, California. 3. Department of Epidemiology, Emory University, Atlanta, Georgia. 4. Surveillance and Health Services Research, American Cancer Society, Atlanta, Georgia. 5. Kaiser Permanente Medical Center, Walnut Creek, California. 6. Department of Family Medicine and Community Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Abstract
INTRODUCTION: Recent studies report racial disparities among individuals in organized colorectal cancer (CRC) programs; however, there is a paucity of information on CRC screening utilization by race/ethnicity among newly age-eligible adults in such programs. METHODS: This was a retrospective cohort study among Kaiser Permanente Northern California enrollees who turned age 50 years between 2007 and 2012 (N=138,799) and were served by a systemwide outreach and facilitated in-reach screening program based primarily on mailed fecal immunochemical tests to screening-eligible people. Kaplan-Meier and Cox model analyses were used to estimate differences in receipt of CRC screening in 2015-2016. RESULTS: Cumulative probabilities of CRC screening within 1 and 2 years of subjects' 50th birthday were 51% and 73%, respectively. Relative to non-Hispanic whites, the likelihood of completing any CRC screening was similar in blacks (hazard ratio, 0.98; 95% CI=0.96, 1.00); 5% lower in Hispanics (hazard ratio, 0.95; 95% CI=0.93, 0.96); and 13% higher in Asians (hazard ratio, 1.13; 95% CI=1.11, 1.15) in adjusted analyses. Fecal immunochemical testing was the most common screening modality, representing 86% of all screening initiations. Blacks and Hispanics had lower receipt of fecal immunochemical testing in adjusted analyses. CONCLUSIONS: CRC screening uptake was high among newly screening-eligible adults in an organized CRC screening program, but Hispanics were less likely to initiate screening near age 50 years than non-Hispanic whites, suggesting that cultural and other individual-level barriers not addressed within the program likely contribute. Future studies examining the influences of culturally appropriate and targeted efforts for screening initiation are needed.
INTRODUCTION: Recent studies report racial disparities among individuals in organized colorectal cancer (CRC) programs; however, there is a paucity of information on CRC screening utilization by race/ethnicity among newly age-eligible adults in such programs. METHODS: This was a retrospective cohort study among Kaiser Permanente Northern California enrollees who turned age 50 years between 2007 and 2012 (N=138,799) and were served by a systemwide outreach and facilitated in-reach screening program based primarily on mailed fecal immunochemical tests to screening-eligible people. Kaplan-Meier and Cox model analyses were used to estimate differences in receipt of CRC screening in 2015-2016. RESULTS: Cumulative probabilities of CRC screening within 1 and 2 years of subjects' 50th birthday were 51% and 73%, respectively. Relative to non-Hispanic whites, the likelihood of completing any CRC screening was similar in blacks (hazard ratio, 0.98; 95% CI=0.96, 1.00); 5% lower in Hispanics (hazard ratio, 0.95; 95% CI=0.93, 0.96); and 13% higher in Asians (hazard ratio, 1.13; 95% CI=1.11, 1.15) in adjusted analyses. Fecal immunochemical testing was the most common screening modality, representing 86% of all screening initiations. Blacks and Hispanics had lower receipt of fecal immunochemical testing in adjusted analyses. CONCLUSIONS: CRC screening uptake was high among newly screening-eligible adults in an organized CRC screening program, but Hispanics were less likely to initiate screening near age 50 years than non-Hispanic whites, suggesting that cultural and other individual-level barriers not addressed within the program likely contribute. Future studies examining the influences of culturally appropriate and targeted efforts for screening initiation are needed.
Authors: A V Diez-Roux; C I Kiefe; D R Jacobs; M Haan; S A Jackson; F J Nieto; C C Paton; R Schulz; A V Roux Journal: Ann Epidemiol Date: 2001-08 Impact factor: 3.797
Authors: Samir Gupta; Daniel A Sussman; Chyke A Doubeni; Daniel S Anderson; Lukejohn Day; Amar R Deshpande; B Joseph Elmunzer; Adeyinka O Laiyemo; Jeanette Mendez; Ma Somsouk; James Allison; Taft Bhuket; Zhuo Geng; Beverly B Green; Steven H Itzkowitz; Maria Elena Martinez Journal: J Natl Cancer Inst Date: 2014-03-28 Impact factor: 13.506
Authors: Betty M Steenkamer; Hanneke W Drewes; Richard Heijink; Caroline A Baan; Jeroen N Struijs Journal: Popul Health Manag Date: 2016-04-28 Impact factor: 2.459
Authors: Chyke A Doubeni; Adeyinka O Laiyemo; Carrie N Klabunde; Angela C Young; Terry S Field; Robert H Fletcher Journal: Am J Prev Med Date: 2010-02 Impact factor: 5.043
Authors: Rebecca L Siegel; Stacey A Fedewa; Kimberly D Miller; Ann Goding-Sauer; Paulo S Pinheiro; Dinorah Martinez-Tyson; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2015-09-16 Impact factor: 508.702
Authors: Briton Lee; Shreya Patel; Carly Rachocki; Rachel Issaka; Eric Vittinghoff; Jean A Shapiro; Uri Ladabaum; Ma Somsouk Journal: J Gen Intern Med Date: 2020-08-03 Impact factor: 5.128
Authors: Cynthia M Mojica; Savannah M Bradley; Bonnie K Lind; Yifan Gu; Gloria D Coronado; Melinda M Davis Journal: Am J Prev Med Date: 2019-11-28 Impact factor: 5.043
Authors: Jennifer L Schneider; Heather Spencer Feigelson; Virginia P Quinn; Carmit McMullen; Pamela A Pawloski; John D Powers; Andrew T Sterrett; David Arterburn; Douglas A Corley Journal: Perm J Date: 2020
Authors: Christoph I Lee; Weiwei Zhu; Tracy Onega; Louise M Henderson; Karla Kerlikowske; Brian L Sprague; Garth H Rauscher; Ellen S O'Meara; Anna N A Tosteson; Jennifer S Haas; Roberta diFlorio-Alexander; Celia Kaplan; Diana L Miglioretti Journal: JAMA Netw Open Date: 2021-02-01